Vincera Pharma Inc
(VINC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 31,463 | 42,609 | 71,191 | 62,656 | 10,714 |
| Operating Income | -31,463 | -42,609 | -71,191 | -62,656 | -10,714 |
| Other Income | 1,389 | 2,452 | 8,207 | 23,350 | -5,906 |
| Pre-tax Income | -30,074 | -40,157 | -62,984 | -39,306 | -16,620 |
| Net Income Continuous | -30,074 | -40,157 | -62,984 | -39,306 | -16,620 |
| Net Income | $-30,074 | $-40,157 | $-62,984 | $-39,306 | $-16,620 |
| EPS Basic Total Ops | -15.85 | -37.72 | -60.00 | -45.80 | -63.20 |
| EPS Basic Continuous Ops | -15.85 | -37.71 | -59.90 | -45.77 | -63.29 |
| EPS Diluted Total Ops | -15.85 | -37.72 | -60.00 | -45.80 | -63.20 |
| EPS Diluted Continuous Ops | -15.85 | -37.71 | -59.90 | -45.77 | -63.29 |
| EPS Diluted Before Non-Recurring Items | -15.85 | -37.80 | -62.20 | -73.00 | -40.80 |
| EBITDA(a) | $-30,584 | $-42,324 | $-70,544 | $-62,316 | $-10,694 |